These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 22288892

  • 1. Comprehensive investigation of common antibody-dependent cell-mediated cytotoxicity antibody epitopes of HIV-1 CRF01_AE gp120.
    Ampol S, Pattanapanyasat K, Sutthent R, Permpikul P, Kantakamalakul W.
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1250-8. PubMed ID: 22288892
    [Abstract] [Full Text] [Related]

  • 2. Common antibody dependent cell mediated cytotoxicity (ADCC) antibody epitopes of HIV-1 CRF01_AE Env and Gag in early HIV-1 infected individuals.
    Sangjan S, Ampol S, Tabprasit S, Horthongkham N, Chuenchitra T, Ekpo P, Kantakamalakul W.
    Asian Pac J Allergy Immunol; 2019 Mar; 37(1):43-50. PubMed ID: 29602284
    [Abstract] [Full Text] [Related]

  • 3. The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides.
    Vogel T, Kurth R, Norley S.
    J Immunol; 1994 Aug 15; 153(4):1895-904. PubMed ID: 7519220
    [Abstract] [Full Text] [Related]

  • 4. Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complement-mediated lysis.
    Posner MR, Elboim HS, Cannon T, Cavacini L, Hideshima T.
    AIDS Res Hum Retroviruses; 1992 May 15; 8(5):553-8. PubMed ID: 1381201
    [Abstract] [Full Text] [Related]

  • 5. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
    Smith SA, Burton SL, Kilembe W, Lakhi S, Karita E, Price M, Allen S, Derdeyn CA.
    Front Immunol; 2018 May 15; 9():3163. PubMed ID: 30697215
    [Abstract] [Full Text] [Related]

  • 6. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects.
    Tyler DS, Stanley SD, Nastala CA, Austin AA, Bartlett JA, Stine KC, Lyerly HK, Bolognesi DP, Weinhold KJ.
    J Immunol; 1990 May 01; 144(9):3375-84. PubMed ID: 2329275
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An adenovirus-based HIV subtype B prime/boost vaccine regimen elicits antibodies mediating broad antibody-dependent cellular cytotoxicity against non-subtype B HIV strains.
    Gómez-Román VR, Florese RH, Peng B, Montefiori DC, Kalyanaraman VS, Venzon D, Srivastava I, Barnett SW, Robert-Guroff M.
    J Acquir Immune Defic Syndr; 2006 Nov 01; 43(3):270-7. PubMed ID: 16940858
    [Abstract] [Full Text] [Related]

  • 11. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.
    Koup RA, Pikora CA, Mazzara G, Panicali D, Sullivan JL.
    Viral Immunol; 1991 Nov 01; 4(4):215-23. PubMed ID: 1726398
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the susceptibility of HIV-1 to a neutralizing antibody KD-247 by nonepitope mutations distant from its epitope.
    Takizawa M, Miyauchi K, Urano E, Kusagawa S, Kitamura K, Naganawa S, Murakami T, Honda M, Yamamoto N, Komano J.
    AIDS; 2011 Nov 28; 25(18):2209-16. PubMed ID: 21866041
    [Abstract] [Full Text] [Related]

  • 13. Flow cytometry-based assay to study HIV-1 gp120 specific antibody-dependent cellular cytotoxicity responses.
    Richard J, Veillette M, Batraville LA, Coutu M, Chapleau JP, Bonsignori M, Bernard N, Tremblay C, Roger M, Kaufmann DE, Finzi A.
    J Virol Methods; 2014 Nov 28; 208():107-14. PubMed ID: 25125129
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
    Acharya P, Tolbert WD, Gohain N, Wu X, Yu L, Liu T, Huang W, Huang CC, Kwon YD, Louder RK, Luongo TS, McLellan JS, Pancera M, Yang Y, Zhang B, Flinko R, Foulke JS, Sajadi MM, Kamin-Lewis R, Robinson JE, Martin L, Kwong PD, Guan Y, DeVico AL, Lewis GK, Pazgier M.
    J Virol; 2014 Nov 28; 88(21):12895-906. PubMed ID: 25165110
    [Abstract] [Full Text] [Related]

  • 16. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP, Kant S, Barbé A, Routy JP, Bruneau J, Lebouché B, Tremblay C, Pazgier M, Finzi A, Bernard NF.
    mBio; 2019 Dec 17; 10(6):. PubMed ID: 31848282
    [Abstract] [Full Text] [Related]

  • 17. Comparison of antibodies that mediate HIV type 1 gp120 antibody-dependent cell-mediated cytotoxicity in asymptomatic HIV type 1-positive men and women.
    Mata MM, Iwema JR, Dell S, Neems L, Jamieson BD, Phair J, Cohen MH, Anastos K, Baum LL.
    AIDS Res Hum Retroviruses; 2014 Jan 17; 30(1):50-7. PubMed ID: 23972002
    [Abstract] [Full Text] [Related]

  • 18. Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.
    Utachee P, Nakamura S, Isarangkura-Na-Ayuthaya P, Tokunaga K, Sawanpanyalert P, Ikuta K, Auwanit W, Kameoka M.
    J Virol; 2010 May 17; 84(9):4311-20. PubMed ID: 20164234
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
    Jewett A, Giorgi JV, Bonavida B.
    J Immunol; 1990 Dec 15; 145(12):4065-71. PubMed ID: 2258607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.